IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

MFN Partners Management, LP

Q2 2019 Holdings

Filed 2019-08-14 | 17 holdings | $3.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Aclaris Therapeutics Inc(ACRS)COM00461U105$3.3M1,500,00084.0%
Allergan PLCSHSG0177J108$150.7K900,1013.9%
FOX Corp(FOXA)CL A COM35137L105$86.8K2,369,3312.2%
PG&E Corp(PCG)COM69331C108$64.2K2,800,0001.6%
Ironwood Pharmaceuticals Inc(IRWD)COM CL A46333X108$54.0K4,939,5411.4%
XPO Logistics Inc(XPO)COM983793100$52.8K913,9351.4%
Cheniere Energy Inc(LNG)COM NEW16411R208$51.3K750,0001.3%
Goldman Sachs Group Inc(GS)COM38141G104$35.6K173,8110.9%
Pioneer NAT RES Co(PXDEUR)COM723787107$30.8K200,0000.8%
FGL HldgsORD SHSG3402M102$25.2K3,000,0000.6%
GTT Communications IncCOM362393100$22.0K1,250,0000.6%
Cyclerion Therapeutics Inc(CYCNUSD)COM23255M105$17.0K1,487,8740.4%
Liberty Global PLCSHS CL CG5480U120$16.6K625,5580.4%
Takeda Pharmaceutical Co LTD(TAK)SPONSORED ADS874060205$13.9K785,0000.4%
Navient Corporation(NAVI)COM63938C108$3.3K244,3000.1%
Evolus Inc(EOLS)COM30052C107$1.8K120,0000.0%
Revance Therapeutics Inc(RVNCEUR)COM761330109$59746,0000.0%